HRT Financial’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

HRT Financial’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,303	Closed	-$312K	–	3865
2021 Q1	$312K	Buy	+8,303	New	+$207K	﹤0.01%	2079
2020 Q4	–	Sell	-16,425	Closed	-$77K	–	2765
2020 Q3	$77K	Sell	16,425 -1,185	-7%	-$6.02K	﹤0.01%	1589
2020 Q2	$107K	Buy	+17,610	New	+$72.5K	﹤0.01%	1239
2020 Q1	–	Sell	-37,690	Closed	-$172K	–	1548
2019 Q4	$172K	Buy	37,690 +23,964	+175%	+$94.9K	0.01%	972
2019 Q3	$53K	Sell	13,726 -229	-2%	-$1.26K	﹤0.01%	1297
2019 Q2	$84K	Buy	+13,955	New	+$133K	0.01%	681

HRT Financial's FPRX Position: Q2 2021 in Review

HRT Financial sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 8,303 shares — an estimated $312K sold.

HRT Financial first reported a position in FPRX in Q2 2019 and held it in 6 quarters. The position peaked at $312K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

HRT Financial reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
HRT Financial sold 8,303 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $312K.
HRT Financial first reported a position in Five Prime Therapeutics, Inc. in Q2 2019 and held it in 6 quarters.
HRT Financial's Five Prime Therapeutics, Inc. position peaked at $312K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.